Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,242 products)
- Hydrocarbon Building Blocks(6,098 products)
- Organic Building Blocks(61,084 products)
Found 198714 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
3-Sulfamoylbenzene-1-sulfonyl fluoride
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H6FNO4S2Purity:Min. 95%Molecular weight:239.2 g/mol3-(2-Methoxyethoxy)benzene-1-sulfonamide
CAS:Versatile small molecule scaffoldFormula:C9H13NO4SPurity:Min. 95%Molecular weight:231.27 g/mol(2S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-3-[4-(methoxycarbonyl)phenyl]propanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C26H23NO6Purity:Min. 95%Molecular weight:445.5 g/molMethyl (2E)-3-(oxan-4-yl)prop-2-enoate
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H14O3Purity:Min. 95%Molecular weight:170.21 g/mol{2-Methoxy-5-[(methylsulfanyl)methyl]phenyl}boronic acid
CAS:Versatile small molecule scaffoldFormula:C9H13BO3SPurity:Min. 95%Molecular weight:212.08 g/mol2-(2,3-Dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)acetic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H9NO4Purity:Min. 95%Molecular weight:195.17 g/molCyclobutyl(cyclopentyl)methanamine
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H19NPurity:Min. 95%Molecular weight:153.26 g/mol4,4-Difluoro-3-(1H-pyrazol-1-yl)butanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H8F2N2O2Purity:Min. 95%Molecular weight:190.15 g/mol3-Benzyl-1-methyl-1H-pyrazole-4-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C12H12N2O2Purity:Min. 95%Molecular weight:216.2 g/mol4-(Heptafluoropropan-2-yl)benzene-1-sulfonyl chloride
CAS:Versatile small molecule scaffoldFormula:C9H4ClF7O2SPurity:Min. 95%Molecular weight:344.63 g/mol2-{[(tert-Butoxy)carbonyl]amino}-3-(thiophen-3-yl)propanoic acid
CAS:Versatile small molecule scaffoldFormula:C12H17NO4SPurity:Min. 95%Molecular weight:271.33 g/mol4-Methyl-2-(4-nitrophenyl)-1,3-thiazole
CAS:Versatile small molecule scaffoldFormula:C10H8N2O2SPurity:Min. 95%Molecular weight:220.25 g/mol2-Chloro-5-(piperidine-1-sulfonyl)benzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H14ClNO4SPurity:Min. 95%Molecular weight:303.76 g/mol4-Chloro-3-[(4-methoxyphenyl)sulfamoyl]benzoic acid
CAS:Versatile small molecule scaffoldFormula:C14H12ClNO5SPurity:Min. 95%Molecular weight:341.8 g/mol4-Chloro-3-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)sulfamoyl]benzoic acid
CAS:Versatile small molecule scaffoldFormula:C18H16ClN3O5SPurity:Min. 95%Molecular weight:421.9 g/mol5-(3-Bromophenyl)-1,3,4-oxadiazol-2-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H6BrN3OPurity:Min. 95%Molecular weight:240.06 g/mol(5S)-5-[(5-Hydroxy-1H-indol-3-yl)methyl]imidazolidine-2,4-dione
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H11N3O3Purity:Min. 95%Molecular weight:245.23 g/molMethyl 4-chloro-2-methoxy-5-nitrobenzoate
CAS:Versatile small molecule scaffoldFormula:C9H8ClNO5Purity:Min. 95%Molecular weight:245.62 g/mol2-Ethyl-1,4-dihydroquinolin-4-one
CAS:Versatile small molecule scaffoldFormula:C11H11NOPurity:Min. 95%Molecular weight:173.21 g/mol2-Pentyl-1,4-dihydroquinolin-4-one
CAS:Versatile small molecule scaffoldFormula:C14H17NOPurity:Min. 95%Molecular weight:215.3 g/mol4-Amino-N-(4,5,6,7-tetrahydro-3H-azepin-2-yl)-benzenesulfonamide
CAS:Controlled Product<p>4-Amino-N-(4,5,6,7-tetrahydro-3H-azepin-2-yl)-benzenesulfonamide is a competitive inhibitor of the antibody binding site on the human IgE receptor. It is used as a research tool and as a cell biology reagent to study the function of some ion channels and receptors. 4-Amino-N-(4,5,6,7-tetrahydro-3H-azepin-2-yl)-benzenesulfonamide binds to an allosteric site on the human IgE receptor. This ligand has been shown to activate the receptor in some systems.</p>Formula:C12H17N3O2SPurity:Min. 95%Molecular weight:267.35 g/mol1-Benzylazepan-4-amine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C13H20N2Purity:Min. 95%Molecular weight:204.31 g/mol1-(3-Chlorophenyl)-2,3-dihydro-1H-imidazol-2-one
CAS:Versatile small molecule scaffoldFormula:C9H7ClN2OPurity:Min. 95%Molecular weight:194.62 g/mol1-Ffluoro-4-[S-(trifluoromethyl)sulfonimidoyl]-benzene
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H5F4NOSPurity:Min. 95%Molecular weight:227.18 g/mol5-Methoxy-4H-chromen-3-one
CAS:<p>5-Methoxy-4H-chromen-3-one is an organic compound that belongs to the group of organocopper compounds. It has been extracted from plants and animals, such as leaves and fruit. This chemical can be used in the production of ethyl esters, which are a type of organic compound. 5-Methoxy-4H-chromen-3-one can also be used in the synthesis of trackable acid ethyl esters, which are used in the detection and identification of drugs.</p>Formula:C10H10O3Purity:Min. 95%Molecular weight:178.18 g/molMethyl cyclopentanecarboximidate hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H14ClNOPurity:Min. 95%Molecular weight:163.64 g/molN7-Benzylpyrimido[4,5-d]pyrimidine-2,4,7-triamine
CAS:Versatile small molecule scaffoldFormula:C13H13N7Purity:Min. 95%Molecular weight:267.29 g/mol3-{5,6-Dimethyl-4-oxo-1H,4H-thieno[2,3-d]pyrimidin-2-yl}propanoic acid
CAS:Controlled Product3-{5,6-Dimethyl-4-oxo-1H,4H-thieno[2,3-d]pyrimidin-2-yl}propanoic acid is an antibody that blocks the activity of ion channels and has a high purity. It is used in cell biology research and as a pharmacological research tool. 3DMPPA is a receptor antagonist and can be used to inhibit or activate the function of peptides or ligands. 3DMPPA binds to receptors on cells, blocking the binding of other compounds and preventing them from activating the receptor. This compound can also be used as an inhibitor or activator of ion channels. 3DMPPA has been shown to have antiinflammatory effects on animal models, which may be due to its inhibition of prostaglandin synthesis by inhibiting cyclooxygenase 1 (COX1) and cyclooxygenase 2 (COX2).Formula:C11H12N2O3SPurity:Min. 95%Molecular weight:252.29 g/mol3-{3-Oxo-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),4-trien-5-yl}propanoic acid
CAS:Versatile small molecule scaffoldFormula:C13H14N2O3SPurity:Min. 95%Molecular weight:278.33 g/mol2-bromo-3-methylbenzaldehyde
CAS:<p>2-Bromo-3-methylbenzaldehyde is an enantiomerically pure stereogenic aldehyde that can be used in the synthesis of quinoline derivatives. This compound has been shown to interact with biomolecules and induce chiral effects. It is also a photochromic molecule that reacts with ultraviolet light to change color, which can be used in the design of cyclic and dihedral molecules. The selective reaction of 2-bromo-3-methylbenzaldehyde with alkyl halides leads to diastereoselective or stereoselective reactions. This compound has been shown to have high yields for these reactions.</p>Formula:C8H7BrOPurity:Min. 95%Molecular weight:199 g/mol1-Benzofuran-2-yl(phenyl)methanamine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C15H14ClNOPurity:Min. 95%Molecular weight:259.73 g/mol6-Bromo-3,4-dihydro-2H-1-benzothiopyran
CAS:Versatile small molecule scaffoldFormula:C9H9BrSPurity:Min. 95%Molecular weight:229.14 g/molMethyl 2-methyl-2H-indazole-3-carboxylate
CAS:Controlled ProductVersatile small molecule scaffoldFormula:C10H10N2O2Purity:Min. 95%Molecular weight:190.2 g/mol4-{5H,6H,7H,8H,9H-[1,2,4]Triazolo[4,3-a]azepin-3-yl}aniline
CAS:Versatile small molecule scaffoldFormula:C13H16N4Purity:Min. 95%Molecular weight:228.29 g/mol(2-Phenoxy-phenyl)-hydrazine HCl
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H12N2O·HClPurity:Min. 95%Molecular weight:236.7 g/mol4H,5H-Imidazo[1,2-a]quinazolin-5-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H7N3OPurity:Min. 95%Molecular weight:185.18 g/mol3H,4H,5H,6H,7H,8H-Pyrido[4,3-d]pyrimidin-4-one dihydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H11Cl2N3OPurity:Min. 95%Molecular weight:224.08 g/mol4-(2,2,3,3-Tetrafluoropropoxy)aniline hydrochloride
CAS:Versatile small molecule scaffoldFormula:C9H10ClF4NOPurity:Min. 95%Molecular weight:259.63 g/mol1-(4-bromophenyl)cyclopropan-1-ol
CAS:<p>1-(4-bromophenyl)cyclopropan-1-ol is an unsaturated, halide reagent that is used to cyclopropanate olefins. It reacts with allylic alcohols and allylic amines to form allylic ethers and amides respectively. 1-(4-Bromophenyl)cyclopropan-1-ol can be used as a diazomethane source for the synthesis of nitrogen containing compounds. This reagent also reacts with allyl alcohols to form vinyl bromides or vinyl iodides. The reaction of 1-(4-bromophenyl)cyclopropan-1-ol with olefins yields sterically hindered alcohols and ethers.</p>Formula:C9H9BrOPurity:Min. 95%Molecular weight:213.07 g/molN,N-Dibenzyl-2-chloropropanamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C17H18ClNOPurity:Min. 95%Molecular weight:287.8 g/mol2-[4-(Benzyloxy)-1H-indol-3-yl]ethan-1-amine
CAS:Controlled Product<p>Versatile small molecule scaffold</p>Formula:C17H18N2OPurity:Min. 95%Molecular weight:266.3 g/molFuro[2,3-b]pyridine-2-carbaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H5NO2Purity:Min. 95%Molecular weight:147.13 g/mol2,2-Dimethyl-1-phenylcyclopropan-1-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H15NPurity:Min. 95%Molecular weight:161.24 g/mol2-(3-Phenoxyphenyl)acetaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H12O2Purity:Min. 95%Molecular weight:212.2 g/mol2-(3,4-Difluorophenyl)acetaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H6F2OPurity:Min. 95%Molecular weight:156.13 g/mol2-(3,5-Dichlorophenyl)acetaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H6Cl2OPurity:Min. 95%Molecular weight:189.04 g/mol2-(4-tert-Butylphenyl)acetaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H16OPurity:Min. 95%Molecular weight:176.25 g/mol(R)-Terazosin
CAS:<p>Terazosin is an alpha-adrenergic receptor antagonist that is used to treat benign prostatic hyperplasia, prostate cancer, and urinary incontinence. It is not a prodrug and does not have any active metabolites. Terazosin inhibits the binding of n-methyl-d-aspartic acid (NMDA) to its receptors in the central nervous system and may act as an NMDA antagonist. Terazosin also binds to soluble guanylate cyclase, which regulates nitric oxide production, leading to relaxation of smooth muscle cells in blood vessels. The drug has been shown to be effective in treating prostate cancer cells in vitro by inhibiting the growth of these cells at concentrations between 10 µM and 1 mM. Terazosin may inhibit the activity of long-term treatment with caco-2 cells at concentrations between 0.1 µM and 100 µM. Terazosin has been shown to bind ferrite at concentrations greater than 100</p>Formula:C19H25N5O4Purity:Min. 95%Molecular weight:387.4 g/mol2,4,4-Trimethylpentane-1,3-diol
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H18O2Purity:Min. 95%Molecular weight:146.23 g/mol3-(2-Aminoethyl)-5-[(4-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H15ClN2O3SPurity:Min. 95%Molecular weight:314.79 g/mol
